Oral Disorders in Sjögren’s Syndrome

1 Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A. Epidemiology of Sjögren’s syndrome: where are we now? Clin Exp Rheumatol. 2007;25(1):1-4. Search in Google Scholar

2 Fox RI. Sjogren’s syndrome. Lancet. 2005;366:321–331 Search in Google Scholar

3 Delaleu N, Jonsson R, Koller MM. Sjogren’s syndrome. Eur J Oral Sci. 2005;113: 101–113. Search in Google Scholar

4 Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjogren’s syndrome: beyond the dryness -From pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;4(3):191-200. Search in Google Scholar

5 Reksten TR, Lessard CJ, Sivils KL. Genetics in Sjogren Syndrome. Rheum Dis Clin North Am. 2016;42(3):435-447. Search in Google Scholar

6 Shah NR, Noll BD, Stevens CB, Brennan MT, Mougeot FB, Mougeot JC. Biosemantics guided gene expression profiling of Sjogren’s syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):192. Search in Google Scholar

7 Low HZ, Witte T. Aspects of innate immunity in Sjögren’s syndrome. Arthritis Res Ther. 2011;27;13(3):218. Search in Google Scholar

8 Kiripolsky J, McCabe LG, Kramer JM. Innate immunity in Sjögren’s syndrome. Clin Immunol. 2017;182:4-13. Search in Google Scholar

9 Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren’s syndrome. Sci Transl Med. 2013;5(195):195ra96. Search in Google Scholar

10 Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2013;9:544-556. Search in Google Scholar

11 Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sjogren’s syndrome: Pathogenicity and plasticity. J Autoimmun. 2018;87:16-25. Search in Google Scholar

12 Zhang LW, Zhou PR, Wei P, Cong X, Wu LL, Hua H. Expression of Interleukin-17 in Primary Sjogren’s Syndrome and the Correlation with Disease Severity: A Systematic Review and Meta-Analysis. Scand J Immunol. 2018;87(4):e12649. Search in Google Scholar

13 Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol. 2008;181: 2898-2906. Search in Google Scholar

14 Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Mirabelli G, Cannarile F, Cipriani P, Giacomelli R, Gerli R. T Regulatory and T Helper 17 Cells in Primary Sjogren’s Syndrome: Facts and Perspectives. Mediators Inflamm. 2015;2015:243723. Search in Google Scholar

15 Fogel O, Riviere E, Seror R, Nocturne G, Boudaoud S, Ly B, et al. Role of the IL-12/IL-35 balance in Sjögren’s syndrome. J Allergy Clini Immunol. 2017; doi: 10.1016/j.jaci.2017.07.041. Search in Google Scholar

16 Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjogren syndrome patients according to serological profiles. J Autoimmunity. 2012;39 (1–2):15–26. Search in Google Scholar

17 Fayyaz A, Kurien BT, Scofield RH. Autoantibodies in Sjögren’s Syndrome. Rheum Dis Clin North Am. 2016;42(3):419-34. Search in Google Scholar

18 Shen L, Suresh L, Lindemann M, Xuan J, Kowal P, Malyavantham K, et al. Novel autoantibodies in Sjogren’s syndrome. Clin Immunol. 2012;145(3):251-5. Search in Google Scholar

19 Reina S, Rodríguez M, Stranieri G, Borda E. Action of anti-M₃muscarinic acetylcholine receptor IgG of primary Sjögren’s syndrome on the enzymatic antioxidant system in rat submandibular gland. J Oral Pathol Med. 2015;44(10):876-883. Search in Google Scholar

20 Kim N, Shin Y, Choi S, Namkoong E, Kim M, Lee J, et al. Effect of Antimuscarinic Autoantibodies in Primary Sjögren’s Syndrome. J Dent Res. 2015;94(5):722-728. Search in Google Scholar

21 Baldini C, Ferro F, Elefante E, Bombardieri S. Biomarkers for Sjögren’s syndrome. Biomark Med. 2018;12(3):275-286. Search in Google Scholar

22 Mariette X, Criswell LA. Primary Sjögren’s Syndrome. N Engl J Med. 2018;378(10):931-939. Search in Google Scholar

23 Kassan SS, Moutsopoulos HM. Clinical Manifestations and Early Diagnosis of Sjögren’s Syndrome. Arch Intern Med. 2004;164:1275-1284. Search in Google Scholar

24 Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8. Search in Google Scholar

25 Milic V, Petrovic R, Boricic I, Radunovic G, Marinkovic-Eric J, Jeremic P, et al. Ultrasonography of major salivary glands could be alternative tool to sialoscintigraphy in the American-European classification criteria for primary Sjogren’s syndrome. Rheumatology (Oxford). 2012;51(6):1081-5. Search in Google Scholar

26 Milic VD,Petrovic RR, Boricic IV, Marinkovic-Eric J, Radunović GL, Jeremic PD, Pejnovic NN, Damjanov NS. (2009) Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren’s syndrome: a comparison with scintigraphy and biopsy. J Rheumatol 36(7):1495-500. Search in Google Scholar

27 Milic VD, Petrovic RR, Boricic IV, Marinkovic-Eric J, Radunović GL, Jeremic PD, et al. Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren’s syndrome: a comparison with scintigraphy and biopsy. J Rheumatol. 2009;36(7):1495-500. Search in Google Scholar

28 Damjanov N, Milic V, Nieto-González JC, Janta I, Martínez-Estupiñan L, Serrano B, et al. Multiobserver Reliability of Ultrasound Assessment of Salivary Glands in Patients with Established Primary Sjögren Syndrome. J Rheumatol. 2016;43(10):1858-1863. Search in Google Scholar

29 Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al; EULAR Sjögren’s Task Force. EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69(6):1103-9. Search in Google Scholar

30 Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al; EULAR Sjögren’s Task Force. EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome. Ann Rheum Dis. 2011;70(6):968-72. Search in Google Scholar

31 Venables PJ. Management of patients presenting with Sjogren’s syndrome. Best Pract Res Clin Rheumatol. 2006;20(4):791-807. Search in Google Scholar

32 Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P. Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev. 2007;6(8):529-36. Search in Google Scholar

33 Seror R, Sordet C, Guillevik L, Hachulla E, Masson C, Ittah M, Candon S, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complictions of primary Sjogrens syndrome. Ann Rheum Dis. 2007;66:351-357. Search in Google Scholar

34 Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren’s syndrome: an open-label phase I/II study. Arthritis Res Ther. 2006;8(4):R129. Search in Google Scholar

35 Nocturne G, Cornec D, Seror R, Mariette X. New biological therapies in Sjogren’s syndrome. Best Pract Res Clin Rheumatol. 2015;29(6):783-793. Search in Google Scholar

36 Turner RJ and Sugiya H. Understanding salivary fluid and protein secretion. Oral diseases. 2002;8: 3-11. Search in Google Scholar

37 Tschoppe P, Wolgin M, Pischon N, Kielbassa AM. Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int. 2010;41:321-33. Search in Google Scholar

38 Gonzalez S, Sung H, Sepulveda D, Gonzalez M, Molina C. Oral manifestations and their treatment in Sjogren’s syndrome. Oral Dis. 2014;20(2):153-161. Search in Google Scholar

39 Tashbayev B, Rusthen S, Young A, Herlofson BB, Hove LH, Singh PB, et al. Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjogren’s Syndrome. Sci Rep. 2017;7(1):10761. Search in Google Scholar

40 Azuma N, Katada Y, Sano H. Deterioration in saliva quality in patients with Sjogren’s syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestations. Inflamm Regen. 2018;38:6. Search in Google Scholar

41 van der Meulen TA, Harmsen HJM, Bootsma H, Liefers SC, Vich Vila A, Zhernakova A, et al. Reduced salivary secretion contributes more to changes in the oral microbiome of patients with primary Sjögren’s syndrome than underlying disease. Ann Rheum Dis. 2018; doi: 10.1136/annrheumdis-2018-213026. Search in Google Scholar

42 Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren’s syndrome from secondary Sjögren’s syndrome and other sicca syndromes. Arthritis Res Ther. 2011;13(6):R194. Search in Google Scholar

43 Baldini C, Cecchettini A, Gallo A, Bombardieri S. Updates on Sjogren’s syndrome: from proteomics to protein biomarkers. Expert Rev Proteomics. 2017;214(6):491-498. Search in Google Scholar

44 Cartee DL, Maker S, Dalonges D, Manski MC. Sjogren’s Syndrome: Oral Manifestations and Treatment, a Dental Perspective. J Dental Hygiene. 2015;89 (6):365-371 Search in Google Scholar

45 Christensen LB, Petersen PE, Thorn JJ, Schiødt M. Dental caries and dental health behavior of patients with primary Sjögren syndrome. Acta Odontol Scand. 2001;59(3):116-20. Search in Google Scholar

46 Lundstrom IM, Lindstorm FD. Subjective and clinical oral symptoms in patients with primary Sjogren’s syndrome. Clin Exp Rheumatol. 1995;13: 725–731. Search in Google Scholar

47 Fox PC, Bowman SJ, Segal B, Vivino FB, Murukutla N, Choueiri K, et al. Oral involvement in primary Sjögren syndrome. J Am Dent Assoc. 2008;139(12):1592-601. Search in Google Scholar

48 Crincoli V, Di Comite M, Guerrieri M, Rotolo RP, Limongelli L, Tempesta A, et al. Orofacial Manifestations and Temporomandibular Disorders of Sjögren Syndrome: An Observational Study. Int J Med Sci. 2018;15(5):475-483. Search in Google Scholar

49 Kamel UF, Maddison P, Whitaker R. Impact of primary Sjögren’s syndrome on smell and taste: effect on quality of life. Rheumatology. 2009;48:1512–1514. Search in Google Scholar

50 Weiffenbach JM, Schwartz LK, Atkinson JC, Fox PC. Taste performance in Sjogren’s syndrome. Physiol Behav. 1995;57: 89–96. Search in Google Scholar

51 Kamel UF, Maddison P, Whitaker R. Impact of primary Sjogren’s syndrome on smell and taste: effect on quality of life. Rheumatology. 2009;48: 1512–1514. Search in Google Scholar

52 Murphy C, Doty RL, Duncan HJ. Clinical disorders of olfaction. In: DOTY RL, ed. Handbook of olfaction and gustation, 2nd ed. Basel and New York: Marcel Dekker, 2003; 461-478. Search in Google Scholar

53 Bromley SM, Doty RL. Clinical disorders affecting taste: evaluation and management. In: DOTY RL, ed. Handbook of olfaction and gustation, 2nd ed. Basel and New York: Marcel Dekker, 2003; 935-958. Search in Google Scholar

54 Grushka M, Ching V, Epstein J. Burning mouth syndrome. Adv Otorhinolaryngol. 2006;63: 278–287. Search in Google Scholar

55 Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev aOral Biol Med. 2003;14: 275–291. Search in Google Scholar

56 Aljanobi H, Sabharwal A, Krishnakumar B, Kramer JM. Is it Sjogren’s syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(4):482-495. Search in Google Scholar

57 Falcao DP, Vieira CN, Batista DE Amorim RF. Breaking paradigms: a new definition for halitosis in the context of pseudo-halitosis and halitophobia. J Breath Res 2012;6:017105. Search in Google Scholar

58 Rusthen S, Young A, Herlofson BB, Aqrawi LA, Rykke M, Hove LH, Palm O, Jensen JL, Singh PB. Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary Sjogren’s syndrome. Eur J Oral Sci. 2017;125(4):265-271. Search in Google Scholar

59 Poon R, Su N, Ching V, Darling M, Grushka M. Reduction in unstimulated salivary flow rate in burnin mouth syndrome. Br Dent J. 2014;217 (7):E14. Search in Google Scholar

60 Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Kazure T, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren’s syndrome. Proc Natl Acad Sci USA. 2006;103: 2770-2775. Search in Google Scholar

61 Pertovaara M, Silvennoinen O, Isomaki P. Cytokine-induced STAT1 activation is increased in patients with primary Sjogren’s syndrome. Clin Immunol. 2016;165: 60-67. Search in Google Scholar

62 Wang H, Zhou M, Brand J, Huang L. Inflammation and taste disorders: mechanisms in taste buds. Ann N Y Acad Sci. 2009;1170: 596-603. Search in Google Scholar

63 Albrecht K, Callhoff J, Westhoff G, Dietrich T, Dorner T, Zink A. The Prevalence of Dental Implants and Related Factors in Patients with Sjogren Syndrome: Results from a Cohort Study. J Rheumatol. 2016;43(7): 1380-1385. Search in Google Scholar

64 Almeida D, Vianna K, Arriaga P, Moraschini V. Dental implants in Sjogren’s syndrome patients: A systematic review. PLoS One. 2017;12(12):e0189507. Search in Google Scholar